Skip to main content
. 2023 Jan 26;24(3):2413. doi: 10.3390/ijms24032413

Figure 1.

Figure 1

Modern approaches to cell-based immunotherapy of melanoma. (A)—NK cell therapy, (B)—B cell therapy, (C)—Macrophage therapy, (D)—T-cell therapy, (E)—Dendritic cell (DC) therapy. This picture is licensed under a Creative Commons Attribution 4.0 International License.